Jenburkt Pharmaceuticals Ltd. BSE: 524731

Mid-range Performer

Download real time

1324.40 -16.90 (-1.26%)

New 52W High in past week

594

BSE Volume

BSE 14 Jul, 2025 11:33 AM (IST)

Jenburkt Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Jenburkt Pharmaceuticals Ltd. on BSE

Search Inside the pdf :

Jenburkt Pharmaceuticals Ltd.

09 Jul 2025

1324.40

-1.26%

Company Update

Jenburkt Pharmaceuticals Ltd - 524731 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate pursuant to Regulation 74(5) of SEBI (D&P) Regulations, 2018 for the quarter ended on 30.06.2025

Jenburkt Pharmaceuticals Ltd.

23 Jun 2025

1324.40

-1.26%

Company Update

Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper publication in pursuance of Rule 20(4) of the companies (Management and Administration) Rules, 2014, in connection with the 40th AGM of the Company.

Jenburkt Pharmaceuticals Ltd.

20 Jun 2025

1324.40

-1.26%

Corp. Action

Jenburkt Pharmaceuticals Ltd - 524731 - Intimation Of Record Date And Cut-Off Date

BSE India

The Company has fixed Friday, 11th July, 2025, as the Record date for the payment of Dividend for the financial year 2024-25 as well as cut- off date for remote e-voting & e-voting during the 40th AGM.

Jenburkt Pharmaceuticals Ltd.

20 Jun 2025

1324.40

-1.26%

AGM

Jenburkt Pharmaceuticals Ltd - 524731 - Notice Of The 40Th Annual General Meeting Of The Company …

BSE India

Notice of the 40th Annual General Meeting Schedule to be held on Friday, 18th July, 2025 through VC/OAVM.

Jenburkt Pharmaceuticals Ltd.

20 Jun 2025

1324.40

-1.26%

Corp. Note

Jenburkt Pharmaceuticals Ltd - 524731 - Reg. 34 (1) Annual Report.

BSE India

Submission of the Annual Report for the FY 2024-25, containing Audited Financial Statements, Auditors Report and Directors Report and the Notice convening 40th Annual General Meeting of the Company.

Jenburkt Pharmaceuticals Ltd.

18 Jun 2025

1324.40

-1.26%

SAST

Jenburkt Pharmaceuticals Ltd - 524731 - Closure of Trading Window

BSE India

Intimation of closure of trading window of Jenburkt Pharmaceuticals Limited as per the SEBI(PIT) Regulations, 2015.

Jenburkt Pharmaceuticals Ltd.

03 Jun 2025

1324.40

-1.26%

Company Update

Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper advertisement for giving notice for the purpose of transfer of unclaimed dividend and corresponding equity shares of the Company to IEPFA.

Jenburkt Pharmaceuticals Ltd.

21 May 2025

1324.40

-1.26%

Company Update

Jenburkt Pharmaceuticals Ltd - 524731 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Annual Secretarial Compliance Report for the financial Year ended on 31st March, 2025.

Jenburkt Pharmaceuticals Ltd.

21 May 2025

1324.40

-1.26%

Company Update

Jenburkt Pharmaceuticals Ltd - 524731 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Publication of Standalone Audited Financial Result for the quarter and financial Year ended on 31st March, 2025.

Jenburkt Pharmaceuticals Ltd.

21 May 2025

1324.40

-1.26%

Corp. Note

Jenburkt Pharmaceuticals Ltd - 524731 - Integrated Filing (Financial)

BSE India

Integrated Filing (Financial) for the quarter and financial year ended on 31st March, 2025.

Is Jenburkt Pharmaceuticals Ltd. worth buying?

27 Votes:

Buy 62.96%

Sell 22.22%

Hold 14.81%